Bianca Costa Soares de Sá

Prof. Dr. Bianca Costa Soares de Sá

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2010 in BMC Cancer
Verified
Journal Article
Open access
PDF file
VBValcinir Bedin
Valcinir Bedin
RARandall L Adam
Randall L Adam
BSBianca Costa Soares de Sá
Bianca Costa Soares de Sá
GLGilles Landman
Gilles Landman
KMKonradin Metze
Konradin Metze
Prognostic factors in malignant melanoma are currently based on clinical data and morphologic examination. Other prognostic features, however, which are not yet used in daily practice, might add important information and thus improve prognosis, treatment, and survival. Therefore a search for new markers is desirable. Previous studies have demonstrated that fractal characteristics of nuclear chromatin are of prognostic importance in neoplasias. We have therefore investigated whether the fractal dimension of nuclear chromatin measured in routine histological preparations of malignant melanomas could be a prognostic factor for survival.

1 January 2011 in Clinics
Verified
Journal Article
Open access
PDF file
JSJuliana Hypólito Silva
Juliana Hypólito Silva
BSBianca Costa Soares de Sá
Bianca Costa Soares de Sá
AÁAlexandre Leon Ribeiro de Ávila
Alexandre Leon Ribeiro de Ávila
GLGilles Landman
Gilles Landman
JNJoão Pedreira Duprat Neto
João Pedreira Duprat Neto
Atypical Mole Syndrome is the most important phenotypic risk factor for developing cutaneous melanoma, a malignancy that accounts for about 80% of deaths from skin cancer. Because the diagnosis of melanoma at an early stage is of great prognostic relevance, the identification of Atypical Mole Syndrome carriers is essential, as well as the creation of recommended preventative measures that must be taken by these patients.

1 December 2004 in Melanoma Research
Verified
Journal Article
Closed access
BSBianca Costa Soares de Sá
Bianca Costa Soares de Sá
GRGisele G Rezze
Gisele G Rezze
ASAna Paula Scramim
Ana Paula Scramim
GLGilles Landman
Gilles Landman
RNRogério I Neves
Rogério I Neves
This study was performed to analyse the behaviour, risk factors, prognosis and evolution of cutaneous melanoma in childhood and adolescence treated in a single institution. A retrospective study was performed between 1980 and 2000 of patients aged 18 years or younger followed at the Hospital do Cancer de Sao Paulo, Brazil. Data included demographic status, risk factors, clinical and histopathological characteristics of the primary and metastatic lesions, stage and follow-up. Seventeen female (53.1%) and 15 male (46.9%) patients were studied. Twelve patients (37.5%) were aged 12 years or younger. The trunk was the most common location (14 patients; 43.8%). Five patients (15.6%) had giant congenital melanocytic naevus, three (9.4%) had xeroderma pigmentosum and one (3%) had dysplastic melanocytic naevus. Nodular melanoma was the most frequent histological type and 43.8% had a thickness of more than 4 mm. Five of the 32 patients (15.6%) were lost to follow-up and 15 (46.9%) were alive at the last year's follow-up, 11 (34.4%) without disease and four (12.5%) with active disease. The 5-year overall survival was 64.34%. An overall survival of 11.71% was found in patients with visceral metastasis with or without cutaneous and/or lymph node involvement, whereas the corresponding value was 90.48% (P value=0.0002) in patients with only cutaneous and/or lymph node metastasis. Cutaneous melanomas are uncommon in the young and are seldom diagnosed in the early stages, perhaps due to a reluctance to accept this diagnosis in this age group. Prevention and early stage diagnosis depend upon the recognition that this disease is present in the young.

1 June 2009 in Melanoma Research
Verified
Journal Article
Closed access
BSBianca Costa Soares de Sá
Bianca Costa Soares de Sá
MFMelissa Lissae Fugimori
Melissa Lissae Fugimori
KRKarina de Cássia Braga Ribeiro
Karina de Cássia Braga Ribeiro
JDjoão Pedreira Duprat
joão Pedreira Duprat
RNRogério Izar Neves
Rogério Izar Neves
GLGilles Landman
Gilles Landman
Cutaneous melanoma is one of the leading causes of cancer-related death. Malignant transformation of epidermal melanocytes is a multifactorial process involving cell cycle and death control pathways. The purpose of this study was to analyze the immunohistochemical expression of cell-cycle-related and apoptosis-related proteins in cutaneous superficial spreading melanomas using the tissue microarray technique to further understand tumor development. A total of 20 samples of in-situ melanomas and 44 melanomas ≤1.0 mm were analyzed in conventional sections whereas 72 melanomas greater than 1.0 mm and 29 metastases were evaluated by tissue microarray. The sections were stained for the following proteins: p16INK4 (p16), cyclin D1, cyclin-dependent kinase 4 (Cdk4), retinoblastoma protein, tumor suppressor protein p53, and p21 cell cycle regulator (p21) using a streptavidine-biotin-peroxidase technique for immunohistochemistry. Thick melanomas (>1.0 mm) and metastases lost p16 expression in 100% of the cases and in-situ and thin melanomas (≤1.0 mm) had low rate of p16 expression (7.9%). When comparing thin versus thick melanomas, thin melanomas showed higher expression of cyclin D1 and cytoplasmatic Cdk4, and thick melanomas had increased expression of nuclear Cdk4, tumor suppressor protein p53, and p21. Primary tumors, when compared with metastases, had higher cytoplasmatic Cdk4 expression. None of the studied proteins influenced overall or disease-free survival. Our results suggest that loss of p16 expression was a constant feature in primary and metastatic melanomas. Cyclin D1 expression seems to be related to initial phases of melanoma development. An increase in p21 expression could represent a cell cycle control in proliferating cells with reduced p16 and/or increased nuclear Cdk4 expression.

1 July 2021 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
CBCarlos Barcaui
Carlos Barcaui
RBRenato Marchiori Bakos
Renato Marchiori Bakos
FPFrancisco Macedo Paschoal
Francisco Macedo Paschoal
FBFlávia Vasques Bittencourt
Flávia Vasques Bittencourt
BSBianca Costa Soares de Sá
Bianca Costa Soares de Sá
HMHelio Miot
Helio Miot
Total body mapping comprises photographic documentation of the entire body surface followed by digital dermatoscopy of selected melanocytic lesions, aiming to compare their evolution over time and identify new lesions. As this is an exam based on comparative analysis of serial dermoscopic body images, standardization of the technique for performing total body mapping is essential. Prepared by specialists from the Brazilian Society of Dermatology, using the modified Delphi method, this article provides recommendations for carrying out total body mapping in Brazil, regarding its indications, technical aspects, and the issuing of the report.

1 June 2018 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
BSBianca Costa Soares de Sá
Bianca Costa Soares de Sá
LMLuciana Facure Moredo
Luciana Facure Moredo
EGElimar Elias Gomes
Elimar Elias Gomes
EAErica Sara Souza de Araújo
Erica Sara Souza de Araújo
JDjoão Pedreira Duprat
joão Pedreira Duprat
Keywords: Inheritance patterns; Melanoma; Neoplastic syndromes, Hereditary; Phenotype; Risk factors; Surveillance